E. Durkan

Serum OPG/TRAIL ratio predicts the presence of cardiovascular disease in people with Type 2 Diabetes Mellitus.

D. O'Gorman, W. Tormey, P. Cummins, 2022, Diabetes research and clinical practice.

Phenotypic Responses to a Lifestyle Intervention Do Not Account for Inter-Individual Variability in Glucose Tolerance for Individuals at High Risk of Type 2 Diabetes

D. O'Gorman, T. Suvitaival, P. Fitzpatrick, 2019, Front. Physiol..

An evaluation of the DEXLIFE ‘self-selected’ lifestyle intervention aimed at improving insulin sensitivity in people at risk of developing type 2 diabetes: study protocol for a randomised controlled trial

D. O'Gorman, A. Kennedy, G. O’Donoghue, 2015, Trials.